Hester Biosciences Limited
Manufacturer and supplier of veterinary vaccines and animal health products with integrated R&D and diagnostic services. Operates multiple manufacturing plants and diagnostic laboratories, supplies poultry, livestock and companion animal products internationally, and undertakes partnerships for immunisation programmes, technology transfer and vaccine R&D. Developing an international manufacturing presence including a planned greenfield vaccine facility in Tanzania.
Industries
Nr. of Employees
Very Large (1000+)
Products
Live attenuated veterinary vaccines (poultry & large animals)
Live vaccines in freeze-dried or liquid formats for prophylactic immunisation against poultry and livestock diseases; multiple administration routes supported.
Inactivated veterinary vaccines (poultry & large animals)
Inactivated vaccines for breeder and commercial flocks and livestock, supplied with recommended vaccination regimens and storage instructions.
Veterinary healthcare products and nutraceuticals
Therapeutic medicines, anti-infectives, probiotics, feed supplements, biosecurity agents and topical/grooming products for production and companion animals.
Pet healthcare products
Companion animal products including anti-infectives, analgesics, liver tonics, dewormers, grooming and nutritional supplements in multiple administration formats.
Live attenuated veterinary vaccines (poultry & large animals)
Live vaccines in freeze-dried or liquid formats for prophylactic immunisation against poultry and livestock diseases; multiple administration routes supported.
Inactivated veterinary vaccines (poultry & large animals)
Inactivated vaccines for breeder and commercial flocks and livestock, supplied with recommended vaccination regimens and storage instructions.
Veterinary healthcare products and nutraceuticals
Therapeutic medicines, anti-infectives, probiotics, feed supplements, biosecurity agents and topical/grooming products for production and companion animals.
Pet healthcare products
Companion animal products including anti-infectives, analgesics, liver tonics, dewormers, grooming and nutritional supplements in multiple administration formats.
Services
Laboratory-based sero-surveillance, diagnostic testing and advisory services to monitor flock immunity, recommend vaccines and plan vaccination schedules. Diagnostic labs located across India.
Manufacture and supply of live and inactivated veterinary vaccines and thermostable variants, with bulk antigen capacity and fill–finish operations for multi-dose vial formats.
Formulation and distribution of non-vaccine animal health products including anti-infectives, probiotics, feed supplements, biosecurity products, and companion animal care items.
Laboratory-based sero-surveillance, diagnostic testing and advisory services to monitor flock immunity, recommend vaccines and plan vaccination schedules. Diagnostic labs located across India.
Manufacture and supply of live and inactivated veterinary vaccines and thermostable variants, with bulk antigen capacity and fill–finish operations for multi-dose vial formats.
Formulation and distribution of non-vaccine animal health products including anti-infectives, probiotics, feed supplements, biosecurity products, and companion animal care items.
Expertise Areas
- Veterinary vaccine development and manufacturing
- Vaccine formulation and lyophilization
- Serological surveillance and diagnostic laboratory services
- Regulatory quality systems for biologics manufacturing
Key Technologies
- Live attenuated and inactivated vaccine production
- Bulk antigen production
- Lyophilization (freeze-drying)
- Sterile fill–finish (vial filling)
News & Updates
Wholly owned subsidiary established in Tanzania to set up a vaccine manufacturing unit with reported capacity of 1.50 billion doses to serve African markets; partially funded by a philanthropic foundation.
Three diagnostic laboratories set up for sero-monitoring and diagnostic services in Kadi (Gujarat), Hyderabad (Telangana) and Kolkata (West Bengal).
Disclosure of outcome for the 37th Annual General Meeting and related shareholder notices.
Quarterly investor presentations, invitations, audio recordings and transcripts for multiple fiscal periods published as investor disclosures.
Announcement about company supply of Goat Pox vaccine to meet demand during an outbreak.
Company announcement detailing response measures during an outbreak of Lumpy Skin Disease.
Wholly owned subsidiary established in Tanzania to set up a vaccine manufacturing unit with reported capacity of 1.50 billion doses to serve African markets; partially funded by a philanthropic foundation.
Three diagnostic laboratories set up for sero-monitoring and diagnostic services in Kadi (Gujarat), Hyderabad (Telangana) and Kolkata (West Bengal).
Disclosure of outcome for the 37th Annual General Meeting and related shareholder notices.
Quarterly investor presentations, invitations, audio recordings and transcripts for multiple fiscal periods published as investor disclosures.
Announcement about company supply of Goat Pox vaccine to meet demand during an outbreak.
Company announcement detailing response measures during an outbreak of Lumpy Skin Disease.